STAT+: GSK to buy RAPT Therapeutics, maker of food allergy treatment, in $2.2B deal
GSK is buying RAPT Therapeutics in a deal worth $2.2 billion, picking up an experimental medicine for food allergies. 
Espace publicitaire · 300×250